CMG Pharmaceuticals (058820), led by CEO Lee Joo-hyung, announced on the 10th that it has rebranded its family-focused health supplement brand to 'Chabiomedical Health', with the launch of its inaugural product 'PDRN Active'. This strategic move is intended to convey the bio-based identity of the Chabiomedical Group more intuitively to consumers.

The newly launched Chabiomedical Health brand positions itself under the slogan, 'Slowing the passage of time for a healthier life', aiming to establish itself as a leader in slow-aging care products. Building on the Chabiomedical Group's competencies in biotechnology and cellular science, the brand plans to expand its offerings for consumers who seek to manage both health and beauty.

'PDRN Active' is the first product introduced by Chabiomedical Health, containing 100mg of salmon-derived extract per film, with 86% of the ingredient being PDRN. The formulation also includes low molecular weight fish collagen, elastin peptides, hyaluronic acid, centella asiatica extract, and vitamin C, designed to appeal to consumers interested in skin elasticity and inner beauty management.

The product utilizes an orally dissolving film (ODF) format, enhancing convenience and absorption as it does not require water for consumption. CMG Pharmaceuticals differentiated itself in the market as the first in South Korea to gain FDA approval for the ODF format, showcasing unique technology and expertise in this category.

CEO Lee Joo-hyung stated, “With the launch of 'PDRN Active', we plan to continuously introduce differentiated health and beauty product lines unique to Chabiomedical Health, contributing to our consumers' healthy and beautiful lives.” This commitment to innovation and consumer engagement indicates a broader strategy aligning with current market demands for integrated health and beauty solutions.

The rebranding and product launch signal CMG Pharmaceuticals’ strategic positioning within the competitive landscape of the health supplement market. By leveraging their technological advancements and focusing on consumer trends toward holistic health products, CMG is poised to enhance customer retention and brand loyalty.

As the industry shifts towards personalized health and beauty management, CMG Pharmaceuticals' strategy may serve as a bellwether for future market dynamics, indicating a growing consumer preference for integrated health solutions that combine wellness and beauty.